Post-earnings recap
Reported
Thu, May 28, 2026
EPS actual
$1.24
EPS est.
$0.94
EPS surprise
+31.63%
1-day move
+4.57%
HealthEquity's strong EPS performance exceeded expectations, leading to a 4.57% increase in stock price. However, the lack of revenue data and guidance leaves some uncertainty about future performance. Investors may be encouraged by the earnings surprise but will be looking for more information in future reports.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.24 | $1.11 | +31.63% |
| Revenue | N/A | $352M | N/A |
No transcript is on record, and the analysis is based on numerical results only.
HealthEquity, Inc. (HQY) operates in the health care sector, focusing on managed health care services. The company provides solutions for health savings accounts and other consumer-directed benefits, which are increasingly important as healthcare costs rise and consumers seek more control over their health expenses.
Last quarter
In Q4-2026, HealthEquity reported an EPS of $0.95, significantly beating expectations of $0.70. The stock reacted positively, gaining nearly 1% the following day.
Management promises and guidance
EPS beat streak
6Q
EPS beat rate
88%
Avg EPS surprise
+32.04%
Avg 1-day reaction
-0.40%
Analysts expect HealthEquity to report strong earnings, with a consensus EPS of $1.11. The company has a solid track record of beating earnings estimates, which may lead to positive market sentiment.
Bull case
If HealthEquity exceeds the EPS estimate, it could signal strong operational efficiency and continued growth in its health savings accounts, leading to a potential stock price increase.
Bear case
Conversely, if the company fails to meet expectations, it may raise concerns about its growth trajectory and operational challenges, potentially leading to a decline in stock value.
Key metrics to watch
EPS
$1.11Earnings per share is a key indicator of profitability and helps investors gauge the company's financial health.
Revenue
$352MRevenue growth is crucial for understanding the company's ability to expand its market share and sustain operations.
The print will turn on these.
Q1
Will HealthEquity's EPS exceed $1.11?
A beat on EPS could reinforce investor confidence and indicate strong operational performance.
Q2
What is the outlook for revenue growth in the upcoming quarters?
Investors will closely watch revenue guidance to assess the company's growth potential and market position.
—
Est. EPS
$1.01
Est. Rev
$543M
Impl. Move
±8.7%
Why consensus could be wrong
The Street may underestimate HealthEquity's ability to leverage its technology for better customer engagement, which could drive higher-than-expected revenue growth.
Supporting evidence
The company's recent initiatives in enhancing user experience may not be fully reflected in current estimates.
Past earnings surprises indicate a trend of operational improvements that could continue this quarter.
Key risk
If revenue growth exceeds $352M, it could challenge the current bearish sentiment.
Pre-commit to what would confirm each case.
This quarter, the focus is on whether HealthEquity can maintain its strong earnings trajectory amidst competitive pressures.
Bull confirmed if
An EPS of $1.14 or higher would confirm the bull case, indicating strong demand and operational efficiency.
Bear confirmed if
An EPS below $1.05 would confirm the bear case, raising concerns about the company's growth prospects.
What the market is pricing for the move.
Implied Move
±9.46%
Historical Avg
±2.4%
The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.
Options are pricing ±7.4% while HQY has averaged ±2.4% over the last 8 prints — setup is pricing rich.
ATM IV
0.5%
30d HV
36.4%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If HealthEquity beats expectations, history suggests a potential stock increase of around 0.02% on the first trading day.
In line / cautious
If results are in line with expectations, the stock may experience muted movement as investors await further guidance.
Miss
Should the company miss earnings expectations, history suggests a potential decline of about 0.94% on the first trading day.
House and Senate STOCK Act disclosures over the trailing 6 months.
Trades
3
3 buys·0 sells
Members
1
House only
Est. Notional
$3,003.00–$45,000.00
disclosed dollar ranges
Most Active Members
3 trades
The lines on the call that would change the story.
Net buying
Recent Transactions
Traded Jul 10, 2026 · disclosed Sep 4, 2026
$1,001.00–$15,000.00
Traded Jun 30, 2026 · disclosed Jul 2, 2026
$1,001.00–$15,000.00
Traded May 29, 2026 · disclosed Jun 8, 2026
$1,001.00–$15,000.00
Filed 30–45+ days after the trade. Treat as positional context, not a leading indicator. Amounts are SEC-mandated dollar ranges, not exact values.